Important Information

THIS WEBSITE IS INTENDED FOR INSTITUTIONAL INVESTORS who are U.S. residents ONLY; not intended for access or distribution to retail investors.

 

In order to access the Capital Group U.S. Institutional website (the “Site”), please read the following information and affirm by clicking the accept button that you have read and understand the information provided.

 

You must attest that you meet the qualifications of an institutional investor as described herein and accept these Terms and Conditions in order to access the Site. Some content may require additional registration for access.

 

The Site is solely intended for U.S. residents who are institutional investors or are acting on behalf of an institutional investor who has agreed to these Terms and Conditions. Institutional investors include, but are not limited to any person acting on behalf of/any pension fund, financial intermediary, consultant, endowment and foundation, bank, savings and loan association, insurance company, investment company registered under the Investment Company Act of 1940, investment adviser registered with the U.S. Securities and Exchange Commission or under applicable state law, government entity, entity with total assets of at least $50 million, employee benefit or qualified retirement plan with at least 100 participants, defined contribution/benefit plan, and qualified client or purchaser as defined by the U.S. Securities and Exchange Commission. By agreeing to these Terms and Conditions you are affirming your understanding that the Site is not intended for retail investors, individual plan participants or others who may not possess the financial sophistication to independently understand the content nor should it be redistributed to such persons.

 

You understand that the Site does not constitute advice of any nature, including fiduciary investment advice by Capital Group or its associates.

 

The reference to “Capital Group” used herein includes The Capital Group Companies, Inc., and its affiliates.

Investment Fund

BACK TO FUND'S DETAIL PAGE

All Holdings

128 Total Holdings:
As of 3/31/25
All Holdings: 1 - 15 of 128
Security Name Asset Type Shares or
Principal Amount 		Market Value Percent of
Net Assets descending arrow
Capital Group Central Cash Fund Short Term 794,596 $79,459,609.00 3.76%
SAP SE Equity 263,008 $69,826,303.00 3.31%
Safran SA Equity 245,590 $64,788,100.00 3.07%
AstraZeneca PLC Equity 356,172 $52,052,669.00 2.47%
London Stock Exchange Group PLC Equity 336,783 $49,942,169.00 2.37%
Rolls-Royce Holdings PLC Equity 5,043,411 $48,762,525.00 2.31%
EssilorLuxottica SA Equity 161,541 $46,472,921.00 2.2%
Novo Nordisk AS, Class B Equity 642,724 $44,548,718.00 2.11%
ASML Holding NV Equity 66,098 $43,736,867.00 2.07%
TotalEnergies SE Equity 574,229 $37,112,842.00 1.76%
Airbus SE, non-registered shares Equity 208,096 $36,692,131.00 1.74%
Amadeus IT Group SA, Class A, non-registered shares Equity 468,188 $35,878,727.00 1.7%
Taiwan Semiconductor Manufacturing Co., Ltd. (ADR) Equity 214,788 $35,654,808.00 1.69%
ABB, Ltd. Equity 651,232 $33,702,048.00 1.6%
Hong Kong Exchanges and Clearing, Ltd. Equity 743,900 $33,092,459.00 1.57%
All Holdings: 1 - 15 of 128